| Dr Jill Ashley Gadzinski, MD | |
|
3577 W 13 Mile Rd Ste 302, Royal Oak, MI 48073-6710 | |
| (248) 551-1330 | |
| (248) 551-5336 |
| Full Name | Dr Jill Ashley Gadzinski |
|---|---|
| Gender | Female |
| Speciality | Gynecological Oncology |
| Experience | 14 Years |
| Location | 3577 W 13 Mile Rd Ste 302, Royal Oak, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427376854 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 125.057414 (Illinois) | Secondary |
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 4301111817 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Beaumont Hospital - Farmington Hills | Farmington hills, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beaumont Medical Group- Specialty Services | 7214299866 | 787 |
News Archive
Qosina is pleased to announce the addition of five new Control Stroke Syringes. These syringes help ensure volume regulation during fluid delivery, and are used for precise injection or withdrawal. All syringes are equipped with a dimple inside the barrel opposite the graduation, which acts as a plunger stop.
Whatever the outcome of healthcare reform, this much is clear: Information technology will play a critical role in the improvement and delivery of patient outcomes. So, will government contractors — they already are. So, who's in the lead?
Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications to address acute and chronic neurodegenerative diseases, announced today the initiation of a clinical efficacy trial examining the effects of AC-1204 in patients with mild-to-moderate Alzheimer's disease (AD).
A cluster of children from Colorado in the USA have been treated for muscle weakness or paralysis that may be connected to a nationwide outbreak of a usually rare respiratory virus called enterovirus D68 (EV-D68), one of more than 100 non-polio enteroviruses.
The results of the Phase 2 program sponsored by Iroko Pharmaceuticals to develop novel, lower-dose formulations of a widely used class of pain medicines will be reported November 7th at the annual meeting of the American College of Rheumatology in Chicago.
› Verified 4 days ago
| Entity Name | Beaumont Medical Group- Specialty Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
Qosina is pleased to announce the addition of five new Control Stroke Syringes. These syringes help ensure volume regulation during fluid delivery, and are used for precise injection or withdrawal. All syringes are equipped with a dimple inside the barrel opposite the graduation, which acts as a plunger stop.
Whatever the outcome of healthcare reform, this much is clear: Information technology will play a critical role in the improvement and delivery of patient outcomes. So, will government contractors — they already are. So, who's in the lead?
Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications to address acute and chronic neurodegenerative diseases, announced today the initiation of a clinical efficacy trial examining the effects of AC-1204 in patients with mild-to-moderate Alzheimer's disease (AD).
A cluster of children from Colorado in the USA have been treated for muscle weakness or paralysis that may be connected to a nationwide outbreak of a usually rare respiratory virus called enterovirus D68 (EV-D68), one of more than 100 non-polio enteroviruses.
The results of the Phase 2 program sponsored by Iroko Pharmaceuticals to develop novel, lower-dose formulations of a widely used class of pain medicines will be reported November 7th at the annual meeting of the American College of Rheumatology in Chicago.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jill Ashley Gadzinski, MD 26901 Beaumont Blvd # 3d, Southfield, MI 48033-3849 Ph: (947) 522-4352 | Dr Jill Ashley Gadzinski, MD 3577 W 13 Mile Rd Ste 302, Royal Oak, MI 48073-6710 Ph: (248) 551-1330 |
News Archive
Qosina is pleased to announce the addition of five new Control Stroke Syringes. These syringes help ensure volume regulation during fluid delivery, and are used for precise injection or withdrawal. All syringes are equipped with a dimple inside the barrel opposite the graduation, which acts as a plunger stop.
Whatever the outcome of healthcare reform, this much is clear: Information technology will play a critical role in the improvement and delivery of patient outcomes. So, will government contractors — they already are. So, who's in the lead?
Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications to address acute and chronic neurodegenerative diseases, announced today the initiation of a clinical efficacy trial examining the effects of AC-1204 in patients with mild-to-moderate Alzheimer's disease (AD).
A cluster of children from Colorado in the USA have been treated for muscle weakness or paralysis that may be connected to a nationwide outbreak of a usually rare respiratory virus called enterovirus D68 (EV-D68), one of more than 100 non-polio enteroviruses.
The results of the Phase 2 program sponsored by Iroko Pharmaceuticals to develop novel, lower-dose formulations of a widely used class of pain medicines will be reported November 7th at the annual meeting of the American College of Rheumatology in Chicago.
› Verified 4 days ago
Dr. Prabhleen Kaur Aneja, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-0845 | |
Theodoros Vlachos, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3535 W 13 Mile Rd Ste 329, Royal Oak, MI 48073 Phone: 248-551-1399 | |
Stefany Acosta-torres, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3577 W 13 Mile Rd Ste 302, Royal Oak, MI 48073 Phone: 248-551-1330 | |
Sonia Sajja, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-5000 | |
Stephanie Yuen Ting Wong, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3535 W 13 Mile Rd Ste 140, Royal Oak, MI 48073 Phone: 248-551-3000 | |
Paula M Fishbaugh, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 30701 Woodward Ave, Suite S200, Royal Oak, MI 48073 Phone: 248-584-7600 Fax: 248-584-7606 | |
Dr. Michael A Genord, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1103 N Main St, Suite E, Royal Oak, MI 48067 Phone: 248-399-7675 |